Replicate instead of Xover [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2015-01-02 00:07 (4195 d 00:32 ago) – Posting: # 14209
Views: 4,321

Hi Angus,

❝ […] the sponsor is given the option of running Single-dose, two-treatment, four-period, two-sequence, fully replicated crossover study in vivo.


Correct. But that’s a trivial statement, right? According to FDA’s practice (for years!) one can always perform a replicate study instead of simple cross-over.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
356 visitors (0 registered, 356 guests [including 22 identified bots]).
Forum time: 01:40 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5